Literature DB >> 17130210

Changes in inflammatory cytokines are related to impaired glucose tolerance in offspring of type 2 diabetic subjects.

Eija Ruotsalainen1, Urpu Salmenniemi, Ilkka Vauhkonen, Jussi Pihlajamäki, Kari Punnonen, Sakari Kainulainen, Markku Laakso.   

Abstract

OBJECTIVE: We sought to determine whether levels of inflammatory markers and different cytokines are abnormal in nondiabetic offspring of type 2 diabetic subjects. RESEARCH DESIGN AND METHODS: Cytokine levels were measured in 19 healthy control subjects and 129 offspring of patients with type 2 diabetes (109 with normal glucose tolerance [NGT] and 20 with impaired glucose tolerance [IGT]). Insulin sensitivity was determined with the hyperinsulinemic-euglycemic clamp, insulin secretion with the intravenous glucose tolerance test, and abdominal fat distribution with computed tomography.
RESULTS: Levels of C-reactive protein and inflammatory cytokines were elevated in nondiabetic offspring of type 2 diabetic subjects. Interleukin (IL)-1beta was increased in the NGT group and decreased in the IGT group. In contrast, levels of IL-1 receptor antagonist (IL-1Ra) were increased in both groups. IL-1beta and -Ra levels correlated inversely (P < 0.05) with rates of whole-body glucose uptake and IL-1beta positively with visceral fat mass (P < 0.05) in normoglycemic offspring.
CONCLUSIONS: Nondiabetic offspring of type 2 diabetic subjects have changes in the levels of inflammatory cytokines. The level of IL-1Ra seems to be the most sensitive marker of cytokine response in the pre-diabetic state.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17130210     DOI: 10.2337/dc06-0147

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  30 in total

Review 1.  Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation.

Authors:  Xiaolun Huang; Daniel J Moore; Robert J Ketchum; Craig S Nunemaker; Boris Kovatchev; Anthony L McCall; Kenneth L Brayman
Journal:  Endocr Rev       Date:  2008-07-29       Impact factor: 19.871

2.  Circulating levels of 8 cytokines and marine n-3 fatty acids and indices of obesity in Japanese, white, and Japanese American middle-aged men.

Authors:  Akira Sekikawa; Takashi Kadowaki; J David Curb; Rhobert W Evans; Hiroshi Maegawa; Robert D Abbott; Kim Sutton-Tyrrell; Tomonori Okamura; Chol Shin; Daniel Edmundowicz; Aya Kadota; Jina Choo; Aiman El-Saed; Hirotsugu Ueshima; Lewis H Kuller
Journal:  J Interferon Cytokine Res       Date:  2010-07       Impact factor: 2.607

Review 3.  Genetic polymorphisms of cytokine genes in type 2 diabetes mellitus.

Authors:  Monisha Banerjee; Madhukar Saxena
Journal:  World J Diabetes       Date:  2014-08-15

4.  Weight loss and low-intensity exercise for the treatment of metabolic syndrome in obese postmenopausal women.

Authors:  Lyndon J Joseph; Ronald L Prigeon; Jacob B Blumenthal; Alice S Ryan; Andrew P Goldberg
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-06-08       Impact factor: 6.053

5.  Association of genetic variants of the α-kinase 1 gene with type 2 diabetes mellitus in a longitudinal population-based genetic epidemiological study.

Authors:  Yoshiji Yamada; Kota Matsui; Ichiro Takeuchi; Mitsutoshi Oguri; Tetsuo Fujimaki
Journal:  Biomed Rep       Date:  2015-03-02

6.  Accelerated increase in serum interleukin-1 receptor antagonist starts 6 years before diagnosis of type 2 diabetes: Whitehall II prospective cohort study.

Authors:  Maren Carstensen; Christian Herder; Mika Kivimäki; Markus Jokela; Michael Roden; Martin J Shipley; Daniel R Witte; Eric J Brunner; Adam G Tabák
Journal:  Diabetes       Date:  2010-02-25       Impact factor: 9.461

7.  Peripheral mononuclear cell resistin mRNA expression is increased in type 2 diabetic women.

Authors:  Panayoula C Tsiotra; Constantine Tsigos; Eleni Anastasiou; Eleni Yfanti; Eleni Boutati; Emmanouil Souvatzoglou; Ioannis Kyrou; Sotirios A Raptis
Journal:  Mediators Inflamm       Date:  2008-12-21       Impact factor: 4.711

8.  Purinergic P2X7 receptors regulate secretion of interleukin-1 receptor antagonist and beta cell function and survival.

Authors:  R Glas; N S Sauter; F T Schulthess; L Shu; J Oberholzer; K Maedler
Journal:  Diabetologia       Date:  2009-04-25       Impact factor: 10.122

9.  Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist precede the onset of type 2 diabetes: the Whitehall II study.

Authors:  Christian Herder; Eric J Brunner; Wolfgang Rathmann; Klaus Strassburger; Adam G Tabák; Nanette C Schloot; Daniel R Witte
Journal:  Diabetes Care       Date:  2008-12-10       Impact factor: 19.112

10.  Gender differences relating to metabolic syndrome and proinflammation in Finnish subjects with elevated blood pressure.

Authors:  Tiina Ahonen; Juha Saltevo; Markku Laakso; Hannu Kautiainen; Esko Kumpusalo; Mauno Vanhala
Journal:  Mediators Inflamm       Date:  2009-08-20       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.